Prevalence of antibodies against the Middle East Respiratory Syndrome coronavirus, influenza A and B viruses among blood donors, Saudi Arabia.

Authors:
Prof. Ali Hajeer, FRCPath
Prof. Ali Hajeer, FRCPath
Manchester University Medical School
Immunology
United Kingdom
Yaseen Arabi
Yaseen Arabi
College of Medicine
Saudi Arabia

Ann Thorac Med 2017 Jul-Sep;12(3):217-218

Department of Intensive Care, College of Medicine, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia E-mail:

Download full-text PDF

Source
http://dx.doi.org/10.4103/atm.ATM_143_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541973PMC
August 2017
7 Reads

Publication Analysis

Top Keywords

influenza viruses
4
coronavirus influenza
4
viruses blood
4
blood donors
4
saudi arabia
4
donors saudi
4
respiratory syndrome
4
syndrome coronavirus
4
prevalence antibodies
4
antibodies middle
4
middle east
4
east respiratory
4
coronavirus
1
saudi
1
arabia
1
donors
1
middle
1
east
1
respiratory
1
influenza
1

Similar Publications

Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015.

Int J Infect Dis 2016 Jun 23;47:10-4. Epub 2016 Apr 23.

Public Health England Birmingham Laboratory, National Infection Service, Heart of England NHS Foundation Trust, Birmingham B9 5SS, UK.

Background: Over 25000 pilgrims from the UK visit Saudi Arabia every year for the Umrah and Hajj pilgrimages. The recent outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea and the continuing reports of MERS-CoV cases from Saudi Arabia highlight the need for active surveillance for MERS-CoV in returning pilgrims or travellers from the Middle East. Public Health England Birmingham Laboratory (PHEBL) is one of a few selected UK public health laboratories responsible for MERS-CoV screening in travellers returning to the UK from the Middle East who present to hospital with severe respiratory symptoms. Read More

View Article
June 2016

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.

Lancet Infect Dis 2015 May 8;15(5):559-64. Epub 2015 Apr 8.

King Abdulaziz Medical City & Advisor Royal Court, Riyadh, Saudi Arabia; Alfaisal University, Riyadh, Saudi Arabia. Electronic address:

Background: Scientific evidence suggests that dromedary camels are the intermediary host for the Middle East respiratory syndrome coronavirus (MERS-CoV). However, the actual number of infections in people who have had contact with camels is unknown and most index patients cannot recall any such contact. We aimed to do a nationwide serosurvey in Saudi Arabia to establish the prevalence of MERS-CoV antibodies, both in the general population and in populations of individuals who have maximum exposure to camels. Read More

View Article
May 2015

Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia.

Emerg Infect Dis 2013 Dec;19(12):2034-6

We used a lentiviral vector bearing the viral spike protein to detect neutralizing antibodies against Middle East respiratory syndrome coronavirus (MERS-CoV) in persons from the Eastern Province of Saudi Arabia. None of the 268 samples tested displayed neutralizing activity, which suggests that MERS-CoV infections in humans are infrequent in this province. Read More

View Article
December 2013

Middle East respiratory syndrome coronavirus in bats, Saudi Arabia.

Emerg Infect Dis 2013 Nov;19(11):1819-23

The source of human infection with Middle East respiratory syndrome coronavirus remains unknown. Molecular investigation indicated that bats in Saudi Arabia are infected with several alphacoronaviruses and betacoronaviruses. Virus from 1 bat showed 100% nucleotide identity to virus from the human index case-patient. Read More

View Article
November 2013